Why the study?
Extensive efforts have been made to identify and develop novel small organic compounds blocking T-type calcium channels, leading to numerous recent patents.
Design
Review of literature and patent databases (2018 to 2025)
Key result
Recent advances from 2018 to 2025 highlight the development of novel small organic compounds targeting T-type calcium channels, with some advancing to clinical trials for non-essential tremor.
Authors
Loading...
Patent review maps emerging T-type channel blockers; leaves open clinical translation for epilepsy, pain, and tremor.
This review highlights recent advances in T-type calcium channel blockers, emphasizing the potential need for subtype-specific inhibitors to avoid adverse effects seen with pan-blockers.
Tamboli et al. (2026) conducted a review in Epilepsy, pain, and non-essential tremor. T-type calcium channel blockers was evaluated. Recent advances from 2018 to 2025 highlight the development of novel small organic compounds targeting T-type calcium channels, with some advancing to clinical trials for non-essential tremor.